Paper Info
Title
Mobile Medical Applications for Melanoma Risk Assessment: False Assurance or Valuable Tool?
Abstract
With the smartphone revolution, consumer-focused mobile medical applications (apps) have flooded the market without restriction. We searched the market for commercially available apps on all mobile platforms that could provide automated risk analysis of the most serious skin cancer, melanoma. We tested 5 relevant apps against 15 images of previously excised skin lesions and compared the apps' risk grades to the known histopathologic diagnosis of the lesions. Two of the apps did not identify any of the melanomas. The remaining 3 apps obtained 80% sensitivity for melanoma risk identification, specificities for the 5 apps ranged from 20%-100%. Each app provided its own grading and recommendation scale and included a disclaimer recommending regular dermatologist evaluation regardless of the analysis outcome. The results indicate that autonomous lesion analysis is not yet ready for use as a triage tool. More concerning is the lack of restrictions and regulations for these applications.
Year
DOI
Venue
2014
10.1109/HICSS.2014.337
System Sciences
Keywords
Field
DocType
relevant apps,analysis outcome,risk grade,mobile platform,valuable tool,mobile medical applications,automated risk analysis,false assurance,available apps,consumer-focused mobile medical application,melanoma risk identification,excised skin lesion,melanoma risk assessment,autonomous lesion analysis
Skin lesion,Risk analysis (business),Simulation,Skin cancer,Risk assessment,Medical physics,Triage,Melanoma,Engineering
Conference
ISSN
Citations 
PageRank 
1060-3425
0
0.34
References 
Authors
0
4
Name
Order
Citations
PageRank
Xavier Chadwick100.34
Lois J. Loescher200.34
Monika Janda320.75
H. Peter Soyer4585.71